HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+12.21%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$290M
AUM Growth
+$290M
(+5.9%)
Cap. Flow
-$2.16M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.51%
Holding
174
New
37
Increased
46
Reduced
48
Closed
32
Top Buys
| 1 |
GE Vernova
GEV
|
$3.75M |
| 2 |
Amgen
AMGN
|
$3.25M |
| 3 |
Protagonist Therapeutics
PTGX
|
$3.07M |
| 4 |
Amazon
AMZN
|
$2.65M |
| 5 |
Edgewise Therapeutics
EWTX
|
$2.37M |
Top Sells
| 1 |
Insmed
INSM
|
$5.94M |
| 2 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$4.02M |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$3.97M |
| 4 |
Merus
MRUS
|
$2.14M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.06M |
Sector Composition
| 1 | Healthcare | 46.45% |
| 2 | Technology | 15.69% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Industrials | 4.98% |
| 5 | Financials | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Microsoft
MSFT
$3.76T
| $3.12M | 1.08% |
7,258
-1,900
| -21% | -$818K |
|
27
Spyre Therapeutics
SYRE
$1.02B
| $3.1M | 1.07% |
105,351
-8,199
| -7% | -$241K |
|
28
Xoma
XOMA
$421M
| $3.03M | 1.05% |
114,548
-4,351
| -4% | -$115K |
|
29
Keros Therapeutics
KROS
$640M
| $3.03M | 1.04% |
52,107
+12,899
| +33% | +$749K |
|
30
Nuvalent
NUVL
$5.74B
| $2.97M | 1.02% |
29,018
+320
| +1% | +$32.7K |
|
31
Xenon Pharmaceuticals
XENE
$2.99B
| $2.9M | 1% |
73,762
+1,047
| +1% | +$41.2K |
|
32
Enliven Therapeutics
ELVN
$1.24B
| $2.87M | 0.99% |
112,459
-7,330
| -6% | -$187K |
|
33
Olema Pharmaceuticals
OLMA
$432M
| $2.53M | 0.87% |
212,185
-35,695
| -14% | -$426K |
|
34
Revolution Medicines
RVMD
$7.43B
| $2.52M | 0.87% |
55,562
+15,479
| +39% | +$702K |
|
35
Cogent Biosciences
COGT
$1.83B
| $2.44M | 0.84% |
225,633
-55,460
| -20% | -$599K |
|
|
36
Edgewise Therapeutics
EWTX
$1.54B
| $2.37M | 0.82% |
+88,838
| New | +$2.37M |
|
37
Dyne Therapeutics
DYN
$1.92B
| $2.35M | 0.81% |
+65,482
| New | +$2.35M |
|
38
PennyMac Financial
PFSI
$5.83B
| $2.2M | 0.76% |
19,337
+6,100
| +46% | +$695K |
|
39
MoonLake Immunotherapeutics
MLTX
$3.78B
| $2.2M | 0.76% |
43,541
+1,292
| +3% | +$65.1K |
|
40
Alibaba
BABA
$325B
| $2.16M | 0.75% |
20,357
+4,300
| +27% | +$456K |
|
41
Alphabet (Google) Class C
GOOG
$2.79T
| $2.1M | 0.72% |
12,536
+1,100
| +10% | +$184K |
|
42
Autodesk
ADSK
$67.9B
| $2.07M | 0.71% |
+7,500
| New | +$2.07M |
|
43
Travere Therapeutics
TVTX
$1.75B
| $2.06M | 0.71% |
147,233
-72,183
| -33% | -$1.01M |
|
44
PTC
PTC
$25.4B
| $2.02M | 0.7% |
11,181
+600
| +6% | +$108K |
|
45
Laureate Education
LAUR
$4.12B
| $2.02M | 0.7% |
121,607
+9,500
| +8% | +$158K |
|
46
Rhythm Pharmaceuticals
RYTM
$6.75B
| $1.96M | 0.68% |
37,426
+23,064
| +161% | +$1.21M |
|
|
AUTL
47
Autolus Therapeutics
AUTL
$383M
| $1.93M | 0.67% |
533,024
+14,204
| +3% | +$51.6K |
|
48
MRC Global
MRC
$1.25B
| $1.91M | 0.66% |
149,800
+15,200
| +11% | +$194K |
|
49
Lithia Motors
LAD
$8.51B
| $1.91M | 0.66% |
+6,000
| New | +$1.91M |
|
50
Delta Air Lines
DAL
$40B
| $1.89M | 0.65% |
+37,200
| New | +$1.89M |
|